A champion of the north-east life sciences sector has stated it may play a number one position within the struggle in opposition to Covid-19 and different trendy well being challenges.
However Professor Stephen Logan additionally warned that corporations not presently engaged on merchandise linked to the pandemic face delays to their analysis and scientific trials, in addition to a decline in investor confidence.
Prof Logan is a fomer chairman of NHS Grampian and now chairman of the life sciences sector board at financial growth physique Alternative North East (One).
His feedback got here as One highlighted the work of all of the north-east corporations, researchers, teachers and clinicians “collaborating and innovating” to deal with the coronavirus pandemic.
The sector’s growth is a regional financial precedence and One is main motion and funding with companions to develop the variety of life sciences corporations in Aberdeen and Aberdeenshire.
In latest weeks, initiatives drawing on internationally-recognised strengths in areas together with biologics and digital well being, in addition to the area’s robust tradition of collaborative innovation have secured new analysis funding value greater than £1 million.
Prof Logan stated: “The life sciences sector is on the forefront of the UK’s response to coronavirus and can make a major contribution to the expansion of our well being economic system.
“Our regional strengths – together with biologics and digital well being – are development areas that may remodel future healthcare supply and affected person outcomes throughout a spread of contemporary well being challenges, together with coronavirus.”
He added: “Life sciences companies not engaged on Covid-19 presently face challenges, together with delays to their analysis initiatives and scientific trials in hospitals, and a common decline in investor confidence.
“Making certain that this high-value sector bounces again as rapidly as potential would require ongoing funding and is a nationwide precedence.
“The motion and funding by One and companions within the area to develop the life sciences sector is extra vital than ever.”